NA ZHOU

Prof. NA ZHOU


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
YHYu Huang
Yu Huang
XZXin Zhang
Xin Zhang
NZNA ZHOU
NA ZHOU
Interleukin-2 (IL-2) is a growth factor that regulates T-cell autocrine secretion and has long been considered to be closely related to immune response. With the advance in neuroinflammation theory and immunology research on schizophrenia, it is interesting and meaningful to discuss the possible role of IL-2 in schizophrenia. Here, we reviewed a series of studies published from the 1990s and found that IL-2 was closely associated with schizophrenia. For example, IL-2 is responsible for mediating toxic reactions, which are the causes of schizophrenia symptoms in patients, and such symptoms resolve after discontinuation of the drug. In addition, we focused on the changes of IL-2 in the onset, progression and treatment of schizophrenia and the possible mechanisms by which IL-2 affects schizophrenia. Our review suggests that IL-2 is associated with schizophrenia and plays a role in its pathogenesis, and progression IL-2 and sIL-2R could serve as potential biomarkers of schizophrenia.

9 January 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
YHYu Huang
Yu Huang
RSRinkiko Suguro
Rinkiko Suguro
WHWei Hu
Wei Hu
JZJiayu Zheng
Jiayu Zheng
YLYawen Liu
Yawen Liu
XZXin Zhang
Xin Zhang
Thyroid carcinoma is the most common endocrine cancer in the world, and its incidence has been steadily increasing in recent years. Despite its relatively good prognosis, therapies have not improved greatly in recent years. Therefore, exploring new therapies for thyroid carcinoma represents an unmet need. Nitric oxide (NO) is a short-term endogenous signaling molecule that plays a vital role in various physiological and pathological processes and is synthesized by nitric oxide synthase (NOS). Many studies have been conducted over the past decades to explain its correlation to cancer. NO exerts a wide range of effects on cancer, involving angiogenesis, apoptosis, cell cycle, invasion, and metastasis. It also serves a dual function by promoting and halting tumor development simultaneously. The relationship between NO and thyroid carcinoma has been intensively studied and discussed. This paper reviews the role and molecular mechanism of NO in thyroid carcinoma and discusses potentials of prevention and treatment of thyroid carcinoma.

20 August 2021 in PeerJ
Verified
Journal Article
Open access
PDF file
YFYingli Fu
Yingli Fu
XRXiaojun Ren
Xiaojun Ren
WBWei Bai
Wei Bai
Qiong YuQiong Yu
Qiong Yu
YSYaoyao Sun
Yaoyao Sun
NZNA ZHOU
NA ZHOU
Background: Schizophrenia is a severely multifactorial neuropsychiatric disorder, and the majority of cases are due to genetic variations. In this study, we evaluated the genetic association between the C-Maf-inducing protein (CMIP) gene and schizophrenia in the Han Chinese population. Methods: In this case-control study, 761 schizophrenia patients and 775 healthy controls were recruited. Tag single-nucleotide polymorphisms (SNPs; rs12925980, rs2287112, rs3751859 and rs77700579) from the CMIP gene were genotyped via matrix-assisted laser desorption/ionization time of flight mass spectrometry. We used logistic regression to estimate the associations between the genotypes/alleles of each SNP and schizophrenia in males and females, respectively. The in-depth link between CMIP and schizophrenia was explored through linkage disequilibrium (LD) and further haplotype analyses. False discovery rate correction was utilized to control for Type I errors caused by multiple comparisons. Results: There was a significant difference in rs287112 allele frequencies between female schizophrenia patients and healthy controls after adjusting for multiple comparisons (χ2 = 12.296, Padj = 0.008). Females carrying minor allele G had 4.445 times higher risk of schizophrenia compared with people who carried the T allele (OR = 4.445, 95% CI [1.788–11.046]). Linkage-disequilibrium was not observed in the subjects, and people with haplotype TTGT of rs12925980–rs2287112–rs3751859–rs77700579 had a lower risk of schizophrenia (OR = 0.42, 95% CI [0.19–0.94]) when compared with CTGA haplotypes. However, the association did not survive false discovery rate correction. Conclusion: This study identified a potential CMIP variant that may confer schizophrenia risk in the female Han Chinese population.

21 January 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MZManfang Zhu
Manfang Zhu
HCHongkui Chen
Hongkui Chen
XCxiaohua chen
xiaohua chen
YZYueyang Zhang
Yueyang Zhang
XCXiayu Chen
Xiayu Chen
XZXin Zhang
Xin Zhang
Background: In cancer immunotherapy, gene therapy has become a promising strategy through the introduction of immunostimulatory components into its formulation. However, ideal non-viral gene delivery platforms capable of simultaneously maintaining a high delivery efficiency and immune activation are still in demand. As an intestinal probiotic, Lactobacillus reuteri has potential correlation with cancer progression. Its unique antigenicity also confers its immunomodulatory activity. Method: We engineered a new non-viral siRNA delivery system, DMPLAC. By wrapping the lysate of Lactobacillus reuteri, it is expected to enhance the anti-cancer immunostimulatory properties. Result: Supported by certain internalization pathways, the prepared DMPLAC nanoparticles showed high siRNA delivery efficiency in vitro (up to 97.62%). They also strongly promoted the maturation and activation of immune cells, including dendritic and T cells, both in vitro and in vivo. By loading siRNA targeting the immune checkpoint CD47 gene, the DMPLAC/siCD47 complex strongly suppressed the growth of multiple colon cancer models through local administration with high safety. Conclusions: Our study developed a novel intestinal probiotic lysate-based gene delivery system with dual immunomodulatory abilities, suggesting a potential strategy for cancer immunotherapy.

2 June 2025 in Biomaterials
Verified
Journal Article
Closed access
JWJieping Wu
Jieping Wu
XFXizi Fu
Xizi Fu
XCXiaohua Chen
Xiaohua Chen
MSMing Shuai
Ming Shuai
MLMohan Liu
Mohan Liu
XDXingmei Duan
Xingmei Duan

8 October 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JZJiayu Zheng
Jiayu Zheng
YHYu Huang
Yu Huang
SZShi Zhong
Shi Zhong
CLChi-Kuan Lio
Chi-Kuan Lio
SVSin Ieng Vong
Sin Ieng Vong
XZXin Zhang
Xin Zhang